Back to top
more

Illumina (ILMN)

(Real Time Quote from BATS)

$94.37 USD

94.37
743,349

-1.13 (-1.18%)

Updated Aug 8, 2025 03:04 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (142 out of 244)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

New Strong Sell Stocks for January 14th

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

Zacks Equity Research

Myriad Genetics (MYGN), Illumina Partner to Enhance Oncology Arm

by Zacks Equity Research

Myriad Genetics (MYGN) partners with Illumina to expand the access as well as extend the reach of myChoice CDx through its services offering in the international market.

Zacks Equity Research

Illumina (ILMN), Helix Partner to Develop Tracking Setup in U.S.

by Zacks Equity Research

Illumina (ILMN) collaborates with Helix with support from the CDC to set up an enhanced surveillance infrastructure to track the emergence and prevalence of B.1.1.7.

Zacks Equity Research

Here's Why You Should Hold on to Illumina (ILMN) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Illumina (ILMN), backed by its focus on partnerships and worldwide expansion to drive growth.

Zacks Equity Research

Illumina (ILMN)-Harvard Pilgrim Partner to Expand WGS Access

by Zacks Equity Research

Illumina (ILMN) signs agreement to expand the availability of WGS to enable faster and cost-effective diagnosis of genetic diseases in children.

Kevin Cook headshot

Scottish Warlords of Investing: Baillie Gifford Sells TSLA, Buys TTD, Holds SHOP

by Kevin Cook

They didn't want to sell Tesla ever, but their profits were just to enormous.

Zacks Equity Research

Here's Why You Should Hold on to Illumina (ILMN) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Illumina (ILMN), backed by its focus on partnerships and worldwide expansion to drive growth.

Zacks Equity Research

Illumina (ILMN) Q3 Earnings Top Estimates, Margins Decline

by Zacks Equity Research

Illumina (ILMN) exhibits dismal segmental performance in the third quarter of 2020 due to pandemic-led business disruptions.

Zacks Equity Research

Illumina (ILMN) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Illumina (ILMN) delivered earnings and revenue surprises of 32.47% and 10.15%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Zacks.com featured highlights include: StoneCo, Las Vegas Sands, Yandex and Illumina

by Zacks Equity Research

Zacks.com featured highlights include: StoneCo, Las Vegas Sands, Yandex and Illumina

Rimmi Singhi headshot

4 Toxic Stocks That You Need to be Wary of & Dump Right Now

by Rimmi Singhi

If you own toxic stocks for a long period of time, you are sure to see huge erosion in your wealth. Figuring out such stocks and selling them at the right time is the key to successful investing.

Zacks Equity Research

CHRS or ILMN: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

CHRS vs. ILMN: Which Stock Is the Better Value Option?

Zacks Equity Research

Illumina (ILMN) to Report Q3 Earnings: What's in the Offing?

by Zacks Equity Research

Illumina (ILMN) is upbeat about its third-quarter sequencing consumable revenue growth.

Zacks Equity Research

Analysts Estimate Illumina (ILMN) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Illumina (ILMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Kevin Cook headshot

7 Diagnostic and Genomic Stocks Storming Into October

by Kevin Cook

COVID-19 has created an Apollo Mission status for advanced medical technologies and smart investors are profiting.

Zacks Equity Research

Stock Market News for Sep 25, 2020

by Zacks Equity Research

Benchmarks closed in the positive territory on Thursday as tech stocks recovered some of the recent losses along with reports of a new stimulus bill in the making by House Democrats.

Zacks Equity Research

ANIK vs. ILMN: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

ANIK vs. ILMN: Which Stock Is the Better Value Option?

Zacks Equity Research

Company News for Sep 22, 2020

by Zacks Equity Research

Companies in the news are: MSFT, ROKU, NKLA, ILMN

Zacks Equity Research

Illumina-CDGN Partner to Create Coronavirus Tracking System

by Zacks Equity Research

Illumina (ILMN) partners with Australia's CDGN to track the national transmission of the virus causing COVID-19.

Zacks Equity Research

Zacks.com featured highlights include: ILMN, PFSW, CCJ and BMRN

by Zacks Equity Research

Zacks.com featured highlights include: ILMN, PFSW, CCJ and BMRN

Rimmi Singhi headshot

These 4 Stocks Could Be Toxic for Your Portfolio

by Rimmi Singhi

Toxic stocks are sure to result in loss for investors over time. Figuring out such stocks on a consistent basis and discarding them at the right time is the key to successful investing.

Zacks Equity Research

Why Is Illumina (ILMN) Down 14.3% Since Last Earnings Report?

by Zacks Equity Research

Illumina (ILMN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Crocs, Illumina, Microsoft, Walmart and Oracle highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Crocs, Illumina, Microsoft, Walmart and Oracle highlighted as Zacks Bull and Bear of the Day

Madeleine Johnson headshot

Bear of the Day: Illumina (ILMN)

by Madeleine Johnson

The coronavirus pandemic has dampened this medical stock's earnings and outlook.

Zacks Equity Research

LGND vs. ILMN: Which Stock Is the Better Value Option?

by Zacks Equity Research

LGND vs. ILMN: Which Stock Is the Better Value Option?